A cikin yanayin e-cigare na yau, cannabidiol (CBD) ya fice a matsayin mashahurin madadin, yana ba da ƙwarewar vaping ta musamman ba tare da tasirin psychotropic da ke da alaƙa da THC, babban ɓangaren psychoactive na cannabis. CBD, wanda aka yi amfani da shi a cikin e-ruwa, gabaɗaya ya fito ne daga lu'ulu'u masu tsabta, yana tabbatar da ƙarancin THC daidai da ƙa'idodin Faransa waɗanda ke sanya matsakaicin abun ciki na 0,2% THC a cikin samfuran tushen hemp.
CBD e-liquids sun ƙunshi tushe na propylene glycol da kayan lambu glycerin, wani lokaci ana wadatar da su da dandano na halitta ko terpenes don inganta dandano. Wannan abun da ke ciki bai ƙunshi nicotine ba, don haka yana bambanta e-ruwa na CBD daga sauran samfuran da aka yi niyya don taimakawa tare da daina shan taba. Mahimmancin CBD ya bambanta, yana ba masu amfani da zaɓi mai yawa don biyan bukatunsu na musamman, daga 10 mg / ml zuwa 50 mg / ml.
Amfani da CBD a cikin nau'in e-ruwa yana da fa'idodi da yawa, gami da sauƙin amfani, haɓaka motsi, da mafi kyawun hankali. Bugu da ƙari, wannan hanyar tana ba da damar ƙarin daidaitattun adadin adadin da kuma bioavailability idan aka kwatanta da sauran nau'ikan amfani, don haka inganta ingantaccen sha na CBD ta jiki.
Amfanin da aka danganta ga CBD sun bambanta, gami da anti-mai kumburi, analgesic, da abubuwan anxiolytic. Wadannan tasiri masu amfani zasu iya taimakawa wajen sarrafa damuwa, rashin barci, ciwo mai tsanani, da wasu yanayi na jijiyoyi. Koyaya, yana da mahimmanci a jaddada cewa CBD ba a gane shi azaman magani ba kuma bai kamata ya maye gurbin maganin da aka tsara ba.
Tambayar halalcin e-ruwa na CBD a Faransa ya dogara ne akan tsauraran sharudda, musamman wajibcin cewa waɗannan samfuran za a samo su daga lu'ulu'u masu tsarki na CBD kuma basu ƙunshi THC fiye da madaidaicin izini ba. Bugu da ƙari, an haramta amfani da furanni na cannabis don hakar CBD, tare da iri da zaruruwa kawai aka halatta.
Don tabbatar da daidaito da ingancin samfuran CBD, yana da kyau a juya zuwa ga masu siyarwa da aka sani da ƙwararrun masu siyarwa, waɗanda ke tabbatar da zaɓi mai tsauri na masu samar da su kuma suna mutunta dokar da ke aiki. Waɗannan ƙwararrun sun himmatu wajen ba da aminci, samfuran inganci waɗanda suka dace da jiyya da tsammanin doka na masu amfani.
Don ci gaba da wannan bincike, tushe kamar binciken da aka buga a cikin sanannun mujallolin kimiyya da rahotanni daga kungiyoyin kiwon lafiyar jama'a suna ba da ƙarin bayanai game da tasiri da amincin CBD. Wannan bayanin yana ba mu damar fahimtar yuwuwar CBD a cikin mahallin vaping da yuwuwar aikace-aikacen warkewa.
Magana:
- "Cannabidiol (CBD) - abin da muka sani da abin da ba mu" na Peter Grinspoon, MD, Harvard Health Publishing, Harvard Medical School.
- "Rahoton Bincike na Cannabidiol (CBD)", Kwamitin Kwararru kan Dogaro da Magunguna, Hukumar Lafiya ta Duniya.
